|
Jul 3
|
Amgen (AMGN) Announces Full Results from Part 1 of the Phase 2 study of MariTide
|
|
Jul 2
|
Amgen (AMGN) Outperforms Broader Market: What You Need to Know
|
|
Jul 2
|
mAbxience Announces European Commission Approval of Denosumab Biosimilars
|
|
Jul 2
|
This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk
|
|
Jul 1
|
Trading Rotation Kicks Off 2nd Half of 2025
|
|
Jul 1
|
Amgen and Zai Lab’s trial of gastric cancer therapy meets primary endpoint
|
|
Jun 30
|
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
|
|
Jun 30
|
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR BEMARITUZUMAB IN FIBROBLAST GROWTH FACTOR RECEPTOR 2b (FGFR2b) POSITIVE FIRST-LINE GASTRIC CANCER
|
|
Jun 30
|
2 Dividend Stocks to Buy on the Dip and Hold Forever
|
|
Jun 28
|
Jim Cramer Says That Amgen’s Stock “Did Not Deserve to Get Hit This Hard”
|
|
Jun 27
|
Amgen Looks to Take Share of Booming Obesity Space: Will It Succeed?
|
|
Jun 27
|
Here's Why Amgen (AMGN) is a Strong Growth Stock
|
|
Jun 27
|
Cancer Vaccine (Preventative, Therapeutic) Market Research 2025 with Analyst Recommendations-Leveraging AI and Bioinformatics for Precision Development / Pursue Fast-Track and Orphan Drug Designations
|
|
Jun 13
|
BMY Focuses on Label Expansion of Drugs: Will This Revive Growth?
|
|
Jun 13
|
Amgen (NASDAQ:AMGN) Has A Pretty Healthy Balance Sheet
|
|
Jun 13
|
AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY
|
|
Jun 12
|
Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider
|
|
Jun 10
|
Why Amgen (AMGN) is a Top Growth Stock for the Long-Term
|
|
Jun 9
|
Why Amgen (AMGN) is a Top Value Stock for the Long-Term
|
|
Jun 9
|
3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff Threats
|